A.Catrin Pharma SRL
A.Catrin Pharma reported total assets of 94,339 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026).
The score of A.Catrin Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
A.Catrin Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
A.Catrin Pharma's financial analysis
- Solvency29.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of A.Catrin Pharma
A.Catrin Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1007.709.640
- VAT number
- BE1007709640
- Peppol
- Registered · 0208:1007709640 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Mar 2024
- Registered office
- 6120 Ham-sur-Heure-Nalinnes
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
A.Catrin Pharma (SRL) has been based in Ham-sur-Heure-Nalinnes since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 16,184 € and equity of 27,311 €; its revenue is not published. Its solvency stands at 29.0%, below the median of its sector (41.5%).
Companies similar to A.Catrin Pharma
Companies in the same business, of comparable size and area, outside its group.
- Antoine Derbaud Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 126,424 €
- Liesap Retail sale of pharmaceutical products Wichelen · balance sheet 72,120 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Panax Retail sale of pharmaceutical products Wemmel · balance sheet 99,320 €
- Kato VAN Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
- VAN Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
- Curasan Retail sale of pharmaceutical products Zwalm · balance sheet 103,974 €
- NT Farma Retail sale of pharmaceutical products Mouscron · balance sheet 56,255 €
Frequently asked questions about A.Catrin Pharma
What is the revenue of A.Catrin Pharma?
A.Catrin Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of A.Catrin Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1007709640 for A.Catrin Pharma, if the company is VAT-registered. Its company number (CBE) is 1007.709.640.
Where is the registered office of A.Catrin Pharma?
According to the CBE register, the registered office of A.Catrin Pharma is in 6120 Ham-sur-Heure-Nalinnes.
What is the equity of A.Catrin Pharma?
At the close of the 2025 financial year, the equity of A.Catrin Pharma amounts to 27,311 €, a solvency of 29.0% of total assets.
Who manages A.Catrin Pharma?
The register lists 1 active mandates at A.Catrin Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of A.Catrin Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →